$0.3827
-0.0052-1.34%
cbdMD (YCBD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
cbdMD (YCBD) ha pubblicato l'ultima guidance il novembre 21, 2025 per Q4 2025. La società ha previsto un fatturato pari a $4.7M - $4.9M per il periodo.
Rispetto alle previsioni precedenti, cbdMD {{epsDirection}} ha modificato le sue previsioni di fatturato da un intervallo precedente di {{epsPriorRange}}.
cbdMD ha pubblicato {{revenueDirection}} aggiornamenti delle previsioni tra il {{revenuePriorRange}} e il cbdMD. 2
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.03 | $-0.05 | $-0.06 | $-0.07 |
| Actual | $-0.11 | $-0.08 | $-0.04 | $-0.08 |
| Surprise | -266.7% | -60.0% | +33.3% | -14.3% |
| Revenue | ||||
| Estimate | $5.7M | $5.3M | $4.9M | $4.7M |
| Actual | $5.6M | $5.6M | $5.0M | $4.7M |
| Surprise | -2.36% | +6.58% | +3.27% | +0.40% |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.09 | $-0.06 |
| Revenue | ||
| Consensus | $5.7M | $6.3M |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Aug 13, 2026 | $-0.11 | $-0.03 | -266.7 % |
| Q2 | May 14, 2026 | $-0.08 | $-0.05 | -60.0 % |
| Q1 | Feb 17, 2026 | $-0.04 | $-0.06 | 33.3 % |
| Q4 | Dec 19, 2025 | $-0.08 | $-0.07 | -14.3 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Aug 13, 2026 | $5.56M | $5.69M | -2.36 % |
| Q2 | May 14, 2026 | $5.64M | $5.29M | 6.58 % |
| Q1 | Feb 17, 2026 | $5.02M | $4.86M | 3.27 % |
| Q4 | Dec 19, 2025 | $4.72M | $4.70M | 0.40 % |